GSK files melanoma drug combination early in race to market
July 09, 2013 at 03:09 AM EDT
LONDON, July 9 (Reuters) - GlaxoSmithKline has filed for U.S. approval of a two-drug combination against melanoma earlier than many industry analysts expected, using data from a mid-stage clinical trial.
